Updated September 2026Two anchors, two storiesBioverse review
The struck-through figures imply a fifty-five percent cut on one line and eleven on the other, with nothing explaining either.
The verdict
Bioverse publishes $129 a month for semaglutide against a struck $289, and $399 for tirzepatide against a struck $449, read August 2026.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $129/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Bioverse sells both molecules by weekly injection. Each carries a price and an anchor above it, and the gap between them differs sharply by line.
Who writes the prescription, and what do they see?
A prescription precedes dispensing. Nothing describes who writes it or how often a case is reviewed.
An anchor is only useful if something explains it. Here one line implies a saving five times the size of the other, and neither anchor is sourced.
What happens when the dose goes up?
Nothing published says what either figure does at a higher dose. No milligram appears beside either.
What the price includes
Six months is $774 on semaglutide and $2,394 on tirzepatide. That is a gap of $1,620 between molecules, which is far wider than most sellers here maintain.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them, and the FDA does not review a compounded preparation before dispensing.
Where it holds up, and where it does not
- Strength: Semaglutide is priced low
- Strength: Both anchors are shown, not hidden
- Strength: Both molecules carry a figure
- Limitation: The two anchors imply unequal discounts
- Limitation: Neither anchor is explained
- Limitation: Tirzepatide costs three times semaglutide
- Limitation: Nothing lists the states served
What the evidence says about this kind of treatment
The assessment above is about Bioverse. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants semaglutide cheaply and ignores the struck figure beside it.
- Wrong for
- A reader treating either anchor as a price anyone has been charged.
How Bioverse compares
| Seller | Who it suits | Go |
|---|---|---|
| Bionomy Health | Readers who want to be able to stop by doing nothing | See Bionomy Health → |
| Society of You | Readers who want tirzepatide and would rather take a tablet than pay more for a shot | See Society of You → |
| Believe Health | Readers who want a low flat rate and know what this storefront actually is | See Believe Health → |
More GLP-1 telehealth sellers reviews: NuvaHealthOakObu HealthOnyx Weight LossOpen Water RxOptions Medical Weight Loss
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What do the struck prices mean?
- Nothing published explains them. They imply a 55% cut on one line and 11% on the other.
- Why is tirzepatide so much dearer?
- The page does not say. The gap is $270 a month.
- What does six months cost?
- $774 for semaglutide or $2,394 for tirzepatide.
- Is Bioverse expensive compared with other GLP-1 telehealth sellers?
- Bioverse publishes a starting figure of $129/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Bioverse below the median, toward the cheaper end. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.